Hayes D. Serum (Circulating) Tumor Markers for Breast Cancer. In: Perry M C, editor. Washington, Boston, San Antonio: American Society of Clinical Oncology, 1997. p. 228- 233.Hayes DF. Serum (circulating) tumor markers for breast cancer. Recent Results Cancer Res. 140, 101-113 (1996)....
Since the well-known serum tumor markers in breast cancer, including CA 15-3 and CEA, do not reflect proliferative activity, TPS may be more beneficial as a prognostic indicator. TPS has consistently been reported as an effective serum marker for providing prognostic information and establishing ...
For breast cancer, however, there are currently very few serum markers used clinically. Some studies have identified as possible breast cancer markers the proteins CA 15.3 [13–15], BR 27.29, tissue polypeptide antigen (TPA), tissue polypeptide specific antigen (TPS), shed HER-2 [15], and ...
In a blind study, 518 serum samples were assayed for serum levels of mammary serum antigen (MSA) by an enzyme immunoassay (EIA) using the 3E1.2 monoclonal antibody. Using 300 IU as the arbitrary cut off to distinguish normal from abnormal individuals, 75% of patients with primary Stage I c...
Serum tumor markers are abnormally elevated in patients with breast cancer. CA 549, MSA, CA 15-3 are useful clinical markers, good indicators of disease extent, and may have important prognostic value. This study demonstrates the role of the tumor markers in breast cancer....
Comment on Eur J Cancer. 2002 Jun;38(9):1189-93. Eur J Cancer. 2002 Jun;38(9):1181-8.doi:10.1016/S0959-8049(02)00069-2K L CheungEuropean Journal of CancerCheung KL (2002) Editorial comment on ’serum markers in breast cancer management’. Eur J Cancer 38:1165–1166...
Serum Markers for Breast Cancer A considerable number of tumour markers and other laboratory tests are used for follow up and evaluation of breast cancer patients. No marker presently ava... Stenman, Ulf-H?kan,R Heikkinen - 《Scandinavian Journal of Clinical & Laboratory Investigation》 被引量...
The role of serum tumour markers in breast cancerdoi:10.1016/0960-9776(95)90032-2ELSEVIERBreast
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view — it ...
Serum markers CASA, CEA, CYFRA 21-1, MSA, NSE, TPA and TPS in lung cancer. Int J Oncol. 1994;4:1129–35. CAS PubMed Google Scholar Ebert W, Muley T. Cyfra 21-1, TPS and NSE in the follow-up of non-small (NSCLC) and small cell lung cancer (SCLC). Anticancer Res. 1998;...